Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
Study NCT ID:
NCT03565458
Status:
UNKNOWN
Last Update Posted:
2018-06-21
First Post:
2018-05-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study
Sponsor:
LG Chem
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-12-22
Completion Date Type:
ESTIMATED
First Submit Date:
2018-05-24
First Submit QC Date:
None
Study First Post Date:
2018-06-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-11
Last Update Post Date:
2018-06-21
Last Update Post Date Type:
ACTUAL